Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter Study
一线帕博利珠单抗单药治疗PD-L1肿瘤比例评分1%至49%的晚期非小细胞肺癌的临床结果:一项回顾性多中心研究
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2026.100953
Miyazaki, Akito; Matsumoto, Kinnosuke; Tamiya, Motohiro; Komuta, Kiyohide; Kanaoka, Kensuke; Kuge, Tomoki; Shiroyama, Takayuki; Tsukaguchi, Akihiro; Tamiya, Akihiro; Yamauchi, Keijiro; Suzuki, Hidekazu; Mihashi, Yasuhiro; Mori, Masahide; Moritomo, Koki; Kinehara, Yuhei; Yoneda, Midori; Morimura, Osamu; Azuma, Kouji; Tanaka, Satoshi; Niki, Toshie; Osa, Akio; Takeda, Yoshito; Kumanogoh, Atsushi